English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  51508670    在线人数 :  844
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"jia horng kao"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 291-315 / 1180 (共48页)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2021-09-04T06:12:28Z Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism is associated with choledocholithiasis in Taiwanese patients Chu C.-H.; Yang A.-M.; JIA-HORNG KAO; Liu C.-Y.; Chang W.-H.; Yang W.-S.
臺大學術典藏 2021-09-04T06:12:27Z High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection Liu C.-J.; Chen P.-J.; Lai M.-Y.; Liu C.-H.; Chen C.-L.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏 2021-09-04T06:12:27Z Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy Liu C.-H.; Liang C.-C.; Liu C.-J.; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:27Z Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D.
臺大學術典藏 2021-09-04T06:12:26Z Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy Hsu C.-S.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:26Z Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B Liu C.-J.; Jeng Y.-M.; Chen C.-L.; Cheng H.-R.; Chen P.-J.; Chen T.-C.; Liu C.-H.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:25Z Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy Tseng T.-C.; Liu C.-J.; Hsieh S.-C.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:25Z IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients Chuang J.Y.; Yang S.S.; Lu Y.T.; Hsieh Y.Y.; Chen C.Y.; Chang S.C.; Chang C.S.; Yeh H.Z.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:24Z Telaprevir for chronic HCV infection JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:24Z Esomeprazole for asthma [7] Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:24Z HBV genotypes and chronicification of acute hepatitis B: More questions than answers Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:24Z Capsule endoscopy versus colonoscopy Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:24Z Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis Tong M.J.; Hsien C.; Song J.J.; JIA-HORNG KAO; Sun H.-E.; Hsu L.; Han S.-H.; Durazo F.A.; Saab S.; Blatt L.M.
臺大學術典藏 2021-09-04T06:12:23Z Hepatitis C virus infection, lipids, and coronary heart disease: A Pandora's box Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:23Z Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease Hsu C.-S.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:23Z Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:22Z Outcomes of HCV treatment: Who does well and who does not? Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:22Z Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection Hsu C.-S.; Liu C.-H.; Liu C.-J.; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:22Z Role of Viral Factors in Modifying Weight-Related Effects on Disease Progression of Chronic Hepatitis C Patients Hsu C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:22Z Alanine aminotransferase, metabolic syndrome, and cardiovascular disease: A missing link Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:21Z Optimal management of hepatocellular carcinoma: Challenges and opportunities Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:21Z Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: A ten-year observation Huang Z.-S.; Huang T.-S.; Wu T.-H.; Chen M.-F.; Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:21Z The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C Liu C.-H.; Liang C.-C.; Liu C.-J.; Hsu S.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:20Z Intrathecal delivery of a mutant μ-opioid receptor activated by naloxone as a possible antinociceptive paradigm JIA-HORNG KAO; Chen S.L.; Ma H.I.; Law P.Y.; Tao P.L.; Loh H.H.
臺大學術典藏 2021-09-04T06:12:20Z Clinical implications of hepatitis B virus variants Lin C.-L.; JIA-HORNG KAO

显示项目 291-315 / 1180 (共48页)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每页显示[10|25|50]项目